(原著)

Nakase Y, Yamaguchi S, Okawa R, Nakano K, Kitagawa H, Imazato S. Physical properties and wear behavior of CAD/CAM resin composite blocks containing S-PRG filler for restoring primary molar teeth. Dent Mater. 38: 158-168, 2022.

Sasaki Y*, Otsugu M*, Sasaki H, Fujikawa N, Okawa R, Kato T, Nakano K. Relationship between dental occlusion and maximum tongue pressure in preschool children aged 4-6 years. Children 9: 141, 2022. * equally contributed

Okawa R, Nakamoto T, Matayoshi S, Nakano K, Kakimoto N. Evaluation of alveolar bone hypomineralization in pediatric hypophosphatasia using orthopantomography. Sci Rep. 12: 1211, 2022.

Suehiro Y, Nomura R, Matayoshi S, Otsugu M, Iwashita N, Nakano K. Evaluation of the collagen-binding properties and virulence of killed Streptococcus mutans in a silkworm model. Sci Rep. 12: 2800, 2022.

Kuremoto K, Okawa R, Matayoshi S, Kokomoto K, Nakano K. Estimation of dental age based on the developmental stages of permanent teeth in Japanese children and adolescents. Sci Rep. 12: 3345, 2022.

Hosoki S, Hattori Y, Saito S, Takegami M, Tonomura S, Yamamoto Y, Ikeda S, Hosomi N, Oishi N, Morita Y, Miyamoto Y, Nomura R, Nakano K, Ihara M. Risk assessment of Cnm-positive Streptococcus mutans in stroke survivors (RAMESSES): Protocol for a multicenter prospective cohort study. Front Neurol. 13, 816147, 2022.

Yoshida S, Inaba H, Nomura R, Nakano K, Matsumoto-Nakano M. Green tea cathecins inhibit Porphyromonas gulae LPS-induced inflammatory responses in human gingival epitheial cells. J Oral Biosci. S1349-0079(22)00091-3, 2022.

Naka S, Matsuoka D, Goto K, Misaki T, Nagasawa Y, Ito S, Nomura R, Nakano K, Matsumoto-Nakano M. Cnm of Streptococcus mutans is important for cell surface structure and membrane permeability. Front Cell Infect Microbiol. 12: 994014, 2022.

Otsugu M, Mikasa Y, Kitamura T, Suhehiro Y, Matayoshi S, Nomura R, Nakano K. Clinical characteristics of children and guardians possessing CBP-positive Streptococcus mutans strains: A cross-sectional study. Sci Rep. 12: 17510, 2022.

Otsuchi T, Ogaya Y, Suehiro Y, Okawa R, Nakano K. Large-scale survey of missing deciduous anterior teeth on medical examination at the age of 3.5 years. Children. 9:1761, 2022.

Urmi AS, Inaba H, Yoshida S, Nomura R, Nakano K, Matsumoto-Nakano M. Characterization of protease from animal periodontal pathogen Porphyromonas gulae. Jpn J Vet Res 70: 79-90, 2022.

(症例報告)

Nagayama K, Ogaya Y, Hamada M, Okawa R, Uzawa N, Nakano K. Severe dislocation of mandibular second premolar associated with deep ankylosis of primary molar. Ped Dent J. 32: 116-122, 2022.

Okawa R, Hamada M, Takagi M, Matayoshi S, Nakano K. A case of X-linked hypophosphatasia rickets with dentin dysplasia in mandibular third molars. Children 9: 1304, 2022.

Hamada M, Nomura R, Matayoshi S, Ogaya Y, Kameyama H, Uzawa N, Nakano K. Detection of Helicobacter pylori from extracted teeth of a patient with idiopathic thrombocytopenic purpura. Microorganisms. 10: 2285, 2022.

Kadota T, Ochiai M, Okawa R, Nakano K. Different dental manifestations in sisters with the same ALPL gene mutation. Children. 9: 1850, 2022.

Okawa R, Yokota Y, Morita Y, Mikasa Y, Nakano K. Osteomyelitis possibly caused by exfoliation of primary teeth in a patient with osteopetrosis. Children. 9: 1894, 2022.

(総説)

Nagasawa Y, Misaki T, Ito S, Naka S, Wato K, Nomura R, Matsumoto-Nakano M, Nakano K. IgA nephropathy and oral bacterial species related to dental caries and periodontitis. Int J Mol Sci. 23: 725, 2022.

Okawa R, Nakano K. Dental manifestation and management of hypophosphatasia. Jpn Dent Sci Rev. 58, 208-216, 2022.

Okawa R, Nakano K. Dental manifestations and oral management of X-linked hypophosphatemia. Endocrines. 3: 654-664, 2022.仲野和彦 歯科領域が関連する感染性心内膜炎―基礎知識と最近の研究成果― 日本臨床矯正学会雑誌 33(2): 9-13, 2022.

野村良太,仲野和彦 歯科衛生士が知っておきたい子どもの歯周疾患 デンタルハイジーン 42(2): 138-144, 2022.

仲野和彦 歯科治療によって引き起こされる感染性心内膜炎炎―う蝕原性細菌の引き起こす循環器疾患の最新の知見を加えて― 日本歯科医師会雑誌75: 420-429, 2022.

仲野和彦 口腔細菌によって引き起こされる歯科疾患と全身疾患―口腔細菌の制御には小児期からのアプローチが重要! 大阪府学校歯科医会雑誌 26:27-30, 2022.

Okawa R, Nakano K. Dental manifestations and oral management of X-linked hypophosphatemia. Endocrines. 3: 654-664, 2022.